No Data
touyun biotech (01332) announced its interim results, with shareholders' attributable loss of 48 million Hong Kong dollars, a 42.9% decrease year-on-year.
Touyun Biotech (01332) released its six-month performance for the period ending June 30, 2024, with revenue of approximately HKD 74.3 million...
Express News | Touyun Biotech Group H1 Net Income HKD -48 Million
Express News | Touyun Biotech Group H1 Revenue HKD 74.3 Million
Express News | Touyun Biotech Group H1 Gross Margin 43.7%
TOUYUN BIOTECH: INTERIM RESULTSFOR THE SIX MONTHS ENDED 30 JUNE 2024
Touyun Biotech Schedules Key Financial Meeting
Some Confidence Is Lacking In Touyun Biotech Group Limited (HKG:1332) As Shares Slide 49%No Data
